9 employees
Isabl integrates the whole genome and transcriptome to inform cancer care.
2020
$3M
from 5 investors over 5 rounds
Isabl raised $3M on May 18, 2022
Investors: Sand Hill Angels, Two Sigma Ventures and Y Combinator
Isabl raised undisclosed on June 1, 2020
Investors: Bossa Nova Investimentos and Y Combinator